Starting-off after Lentigen's acquisition, we continuously evolved to become your dedicated partner for developing and manufacturing lentiviral vectors for immuno-oncology and gene therapy applications using a predictive and scalable platform process. We have reduced the need for engineering runs while simultaneously accelerating cell manufacturing process development to fast-track the path towards commercial manufacturing. Our commercialization-enabling services include critical process characterization and process performance qualification, and also regulatory support.
Our platform and regulatory experience in key markets worldwide will help your product succeed: Getting into the clinic and onto the market to support patient needs as soon as possible.
As your key contact, our project management team will be with you from initiation to completion of our services. Your personally assigned project manager will be responsible for setting up a precise project definition, informing you about progress, and answering all your questions. Throughout development and manufacturing, your lentiviral vector project will receive expertise from highly-qualified, experienced staff.
